Householder Group Estate & Retirement Specialist’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History

Householder Group Estate & Retirement Specialist’s Portfolio HZNP Stock Details HZNP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	$15K	Hold	138	–	–	0.01%	708
2022 Q4	$15K	Hold	138	–	–	0.02%	196
2022 Q3	$8K	Buy	+138	New	+$9.64K	﹤0.01%	796

Other funds holding HZNP

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return

HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

DKCM

Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Householder Group Estate & Retirement Specialist's HZNP Position: Q1 2023 in Review

Householder Group Estate & Retirement Specialist held its Horizon Therapeutics Public Limited Company Ordinary Shares (HZNP) position steady in Q1 2023 at 138 shares worth $15K. The position accounts for 0.01% of the portfolio, ranked #708.

Householder Group Estate & Retirement Specialist first reported a position in HZNP in Q3 2022 and has held it in 3 quarters since. 553 funds tracked by Wall St. Rank hold HZNP as of Q1 2023.

Householder Group Estate & Retirement Specialist held 138 shares of Horizon Therapeutics Public Limited Company Ordinary Shares worth $15K as of Q1 2023.
Householder Group Estate & Retirement Specialist left its Horizon Therapeutics Public Limited Company Ordinary Shares share count unchanged in Q1 2023.
Horizon Therapeutics Public Limited Company Ordinary Shares made up 0.01% of Householder Group Estate & Retirement Specialist's portfolio in Q1 2023, its #708 holding.
Householder Group Estate & Retirement Specialist first reported a position in Horizon Therapeutics Public Limited Company Ordinary Shares in Q3 2022 and has held it in 3 quarters since.
553 funds tracked by Wall St. Rank held Horizon Therapeutics Public Limited Company Ordinary Shares as of Q1 2023.

Based on Householder Group Estate & Retirement Specialist's 13F filing for Q1 2023, filed 13 Apr 2023.